Life Science Product News

This reformulated kit increases the sensitivity and specificity of RNA detection by Droplet Digital™ PCR, permitting quantification of low abundance RNA species and detection of even smaller differences in gene expression.

The ddPCR™ Supermix for Residual DNA Quantification simplifies the quality control process by enabling highly sensitive quantification of host cell DNA without DNA purification.

Scientists use Droplet Digital PCR to identify and validate a potential new biomarker for breast cancer. Study demonstrates potential clinical utility of Droplet Digital PCR.

Bio-Rad Laboratories will complete a business systems update on July 6. Impacts to business operations will be minimal, but North American customers should note that Bio-Rad will not ship products from July 1–July 5; shipping will resume on July 6. New customer account numbers and other changes to customer-facing data formats will also be implemented on this date.

New line of antibodies raises industry standards for antibody validation and ensures western blotting success.

Researchers publish a new method facilitating the study of how the distribution of mutations between alleles affects disease states.

Scientists take advantage of fully wet-lab validated human PrimePCR Assays to support an FDA-led Sequencing Quality Control (SEQC) study published in Nature Biotechnology.

The newest addition to Bio-Rad’s S3e Cell Sorter family is equipped with 488 nm and 640 nm lasers that permit excitation and detection of red fluorophores common to many immunology experiments.

New kits for copy number detection enable precise and reproducible high-throughput copy number calls for SMN1 and SMN2.

Researchers highlight different applications of ddPCR™ technology in cancer research, including the development of a highly sensitive test for the detection of oncogene amplifications, detection of gene mutations arising from drug resistance, and the use of multiplexing to detect several cancer-associated mutations in a single assay.